Ju Ry Lim

Title: Ju Ry Lim: Innovator in Modified DKK2 Protein Technology

Introduction

Ju Ry Lim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of modified proteins that have potential therapeutic applications. His work focuses on enhancing the properties of proteins to improve their efficacy in medical treatments.

Latest Patents

Ju Ry Lim holds a patent for a modified DKK2 protein, which includes a nucleic acid encoding the same, a preparation method, and its various uses. This innovation provides a modified DKK2 polypeptide that features an additional glycosyl group or improved binding affinity for the substrate LRP6. The advancements in this technology allow for efficient preparation of the modified DKK2 protein, which can be utilized for promoting angiogenesis or for the prevention and treatment of diseases related to vascular permeability.

Career Highlights

Throughout his career, Ju Ry Lim has worked with notable companies in the biotechnology sector, including Medpacto Inc. and Biocomplete Inc. His experience in these organizations has contributed to his expertise in protein modification and therapeutic applications.

Collaborations

Ju Ry Lim has collaborated with esteemed colleagues such as Il Ho Ha and Seok Ho Yoo. These partnerships have further enriched his research and development efforts in the field of biotechnology.

Conclusion

Ju Ry Lim is a distinguished inventor whose work on modified DKK2 proteins holds promise for advancing medical treatments. His contributions to biotechnology reflect a commitment to innovation and improving health outcomes.